Chengdu Huasun Group Inc Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: -0.142x

Chengdu Huasun Group Inc Ltd cash flow conversion efficiency. Based on the latest financial reports, Chengdu Huasun Group Inc Ltd (000790) has a cash flow conversion efficiency ratio of -0.142x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-134.75 Million ≈ $-19.72 Million USD) by net assets (CN¥949.82 Million ≈ $138.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Chengdu Huasun Group Inc Ltd market cap and net worth for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of Chengdu Huasun Group Inc Ltd (1998–2024)

Cash flow conversion efficiency of Chengdu Huasun Group Inc Ltd from 1998 to 2024. This chart illustrates how Chengdu Huasun Group Inc Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 000790 stock price and chart for real-time trading data and today's change.

Chengdu Huasun Group Inc Ltd Cash Flow Conversion Ratio Explained

Chengdu Huasun Group Inc Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Chengdu Huasun Group Inc Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chengdu Huasun Group Inc Ltd ranked by their cash flow conversion efficiency. Review free cash flow generation of Chengdu Huasun Group Inc Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Company Cash Flow Conversion Efficiency
KKR Real Estate Finance Trust Inc
NYSE:KREF
0.028x
RattanIndia Power Limited
NSE:RTNPOWER
0.081x
Zhejiang Baida Precision Mnfg
SHG:603331
0.085x
Chengdu Dahongli Machinery Co Ltd
SHE:300865
0.015x
CapsoVision, Inc. Common Stock
NASDAQ:CV
-0.638x
medmix AG
SW:MEDX
0.086x
Third Point Investors Limited
LSE:TPOU
-0.004x
Metrics Income Opportunities Trust
AU:MOT
0.041x

Annual Cash Flow Conversion Efficiency for Chengdu Huasun Group Inc Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Chengdu Huasun Group Inc Ltd from 1998 to 2024. Also see Chengdu Huasun Group Inc Ltd (000790) total assets for a full breakdown of the balance sheet.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥1.07 Billion
≈ $156.28 Million
CN¥64.28 Million
≈ $9.41 Million
0.060x +36.64%
2023-12-31 CN¥1.08 Billion
≈ $157.51 Million
CN¥47.41 Million
≈ $6.94 Million
0.044x -71.59%
2022-12-31 CN¥1.01 Billion
≈ $147.14 Million
CN¥155.89 Million
≈ $22.81 Million
0.155x +373.47%
2021-12-31 CN¥981.44 Million
≈ $143.61 Million
CN¥-55.64 Million
≈ $-8.14 Million
-0.057x -483.30%
2020-12-31 CN¥912.45 Million
≈ $133.52 Million
CN¥13.50 Million
≈ $1.97 Million
0.015x -79.97%
2019-12-31 CN¥880.71 Million
≈ $128.88 Million
CN¥65.03 Million
≈ $9.52 Million
0.074x -42.74%
2018-12-31 CN¥835.55 Million
≈ $122.27 Million
CN¥107.74 Million
≈ $15.77 Million
0.129x +455.61%
2017-12-31 CN¥838.86 Million
≈ $122.75 Million
CN¥-30.42 Million
≈ $-4.45 Million
-0.036x -146.80%
2016-12-31 CN¥665.85 Million
≈ $97.43 Million
CN¥51.59 Million
≈ $7.55 Million
0.077x +174.68%
2015-12-31 CN¥583.35 Million
≈ $85.36 Million
CN¥-60.53 Million
≈ $-8.86 Million
-0.104x -256.97%
2014-12-31 CN¥632.30 Million
≈ $92.53 Million
CN¥-18.38 Million
≈ $-2.69 Million
-0.029x -148.83%
2013-12-31 CN¥585.45 Million
≈ $85.67 Million
CN¥34.85 Million
≈ $5.10 Million
0.060x +169.98%
2012-12-31 CN¥545.88 Million
≈ $79.88 Million
CN¥-46.44 Million
≈ $-6.80 Million
-0.085x -169.87%
2011-12-31 CN¥492.53 Million
≈ $72.07 Million
CN¥59.97 Million
≈ $8.77 Million
0.122x -51.64%
2010-12-31 CN¥460.83 Million
≈ $67.43 Million
CN¥116.01 Million
≈ $16.98 Million
0.252x +242.21%
2009-12-31 CN¥402.43 Million
≈ $58.89 Million
CN¥29.60 Million
≈ $4.33 Million
0.074x +153.97%
2008-12-31 CN¥414.42 Million
≈ $60.64 Million
CN¥12.00 Million
≈ $1.76 Million
0.029x +469.78%
2007-12-31 CN¥414.55 Million
≈ $60.66 Million
CN¥2.11 Million
≈ $308.37K
0.005x -88.28%
2006-12-31 CN¥427.78 Million
≈ $62.60 Million
CN¥18.56 Million
≈ $2.72 Million
0.043x -17.81%
2005-12-31 CN¥423.41 Million
≈ $61.96 Million
CN¥22.35 Million
≈ $3.27 Million
0.053x +84.70%
2004-12-31 CN¥434.58 Million
≈ $63.59 Million
CN¥12.42 Million
≈ $1.82 Million
0.029x -67.09%
2003-12-31 CN¥417.14 Million
≈ $61.04 Million
CN¥36.23 Million
≈ $5.30 Million
0.087x +320.05%
2002-12-31 CN¥407.64 Million
≈ $59.65 Million
CN¥8.43 Million
≈ $1.23 Million
0.021x -64.00%
2001-12-31 CN¥422.61 Million
≈ $61.84 Million
CN¥24.27 Million
≈ $3.55 Million
0.057x -1.18%
2000-12-31 CN¥271.28 Million
≈ $39.70 Million
CN¥15.77 Million
≈ $2.31 Million
0.058x -0.08%
1999-12-31 CN¥236.56 Million
≈ $34.62 Million
CN¥13.76 Million
≈ $2.01 Million
0.058x -77.02%
1998-12-31 CN¥220.50 Million
≈ $32.27 Million
CN¥55.81 Million
≈ $8.17 Million
0.253x --

About Chengdu Huasun Group Inc Ltd

SHE:000790 China Drug Manufacturers - Specialty & Generic
Market Cap
$352.30 Million
CN¥2.41 Billion CNY
Market Cap Rank
#14016 Global
#4191 in China
Share Price
CN¥3.86
Change (1 day)
-1.53%
52-Week Range
CN¥3.49 - CN¥4.68
All Time High
CN¥21.66
About

Chengdu huasun technology group Inc. , LTD. manufactures and sells medicines, bio-pharmaceutical products, and building steel structures. The company manufactures modern Chinese medicines, Chinese patent medicines, chemical medicines, and drugs. It also engages in the research and development, production, and sale of biological products and biotechnology drugs; and medicines for the treatment of … Read more